Glaxo Wins FDA Approval for HIV Treatment From Joint Venture

GlaxoSmithKline Plc won U.S. regulatory approval for a daily pill against the deadly HIV infection that was developed by ViiV Healthcare Ltd., its joint venture with two other drugmakers.

http://washpost.bloomberg.com/Story?docId=1376-MRFRT96TTDSC01-429BHIR4KQLC702EC4DPUBMJTH